SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SILO

Silo Pharma Inc.
NASDAQHealth Care

Latest close: 1.18 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 2, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 19, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year249
SEC filings on record33825 flagged findings
Reported transactions (Form 4)39since May 17, 2023
Corporate events (8-K)30since Sep 30, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-18listing compliance noticerecentOpen filing ↗
    “…the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the…”
    +1 more passage from the same document
    • “…Pharma, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market…”
  • 2026-06-03reverse splitrecentOpen filing ↗
    “…information contained in Item 5.03 of this report is incorporated herein by reference. Item 5.03 Amendments to Articles of…”
    +1 more passage from the same document
    • “…5.03 of this report is incorporated herein by reference. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in…”
  • 2026-06-01reverse splitrecentOpen filing ↗
    “…If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for…”
    +1 more passage from the same document
    • “…☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period…”
  • 2026-05-14bitcoin treasury exposurerecentOpen filing ↗
    “…peptides to reduce toxicity while enhancing therapeutic payload delivery. Cryptocurrency Treasury Strategy Our strategy changed to…”
    +1 more passage from the same document
    • “…to reduce toxicity while enhancing therapeutic payload delivery. Cryptocurrency Treasury Strategy Our strategy changed to include…”
  • 2026-05-14business pivot to crypto/bitcoinrecentOpen filing ↗
    “…peptides to reduce toxicity while enhancing therapeutic payload delivery. Cryptocurrency Treasury Strategy Our strategy changed to…”
    +1 more passage from the same document
    • “…advantage by using homing peptides to reduce toxicity while enhancing therapeutic payload delivery. Cryptocurrency Treasury…”
  • 2026-05-14share offering or dilution eventrecentOpen filing ↗
    “…and Exchange Commission on January 30, 2024 and a related base prospectus and prospectus supplements thereunder. Concurrently…”
    +1 more passage from the same document
    • “…the sale of the October 2025 Shares pursuant to the September 2025 Purchase Agreement in a private placement, for each October 2025…”
  • 2026-05-14capital return (buybacks/dividends)recentOpen filing ↗
    “…and covenants of the parties that are customary for agreements of its type. In addition, Many Ads agreed to indemnify the…”
    +1 more passage from the same document
    • “…Many Ads agreed to indemnify the Company for any misrepresentation or breach under the Many Ads Agreement, infringement of…”
  • 2026-04-16bitcoin treasury exposurerecentOpen filing ↗
    “…The following table summarizes our product development pipeline. Cryptocurrency Treasury Strategy Our strategy changed to include…”
    +1 more passage from the same document
    • “…table summarizes our product development pipeline. Cryptocurrency Treasury Strategy Our strategy changed to include…”

5 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Dec 29, 2025).

Open the 8-K at the SEC

Reverse splits in 5 years

2 reverse splits in 5 years (1:50 on Sep 15, 2022, 1:15 on Jun 3, 2026) · 1:750 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 338)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 14, 268-K ↗Current report · Sold unregistered shares new
  • Oct 2, 268-K ↗Current report · Entered a material agreement
  • Aug 19, 268-K ↗Current report · Sold unregistered shares
  • Aug 17, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Mitchell P. Kopin · 10.0% · event on Jun 30, 26 · amendment
  • Aug 6, 26424B3 ↗Securities offering
  • Jul 24, 26S-3 ↗Securities offering
  • Jul 13, 268-K ↗Current report · Sold unregistered shares
  • Jul 8, 26SCHEDULE 13G ↗Passive stake · AdvisorShares Trust · 6.7% · event on Jun 30, 26
  • Jun 30, 26DEFA14A ↗Shareholder meeting and votes
  • Jun 30, 26DEF 14A ↗Shareholder meeting and votes
  • Jun 18, 268-K ↗Current report · Other events
  • Jun 18, 26PRE 14A ↗Shareholder meeting and votes
  • Jun 3, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change · Other events
  • Jun 1, 268-K ↗Current report · Other events
  • May 14, 2610-Q ↗Quarterly report
  • Apr 16, 26424B3 ↗Securities offering
  • Apr 14, 26424B3 ↗Securities offering
  • Apr 14, 26POS AM ↗Securities offering
  • Apr 10, 26POS AM ↗Securities offering
  • Apr 2, 268-K ↗Current report · Sold unregistered shares
  • Mar 27, 2610-K ↗Annual report
  • Feb 23, 268-K ↗Current report · Sold unregistered shares
  • Feb 17, 26SCHEDULE 13G/A ↗Passive stake · Anson Funds Management LP · 4.9% · event on Dec 31, 25 · amendment

338 filings on record, the oldest from Mar 30, 11.

Listing the 25 most recent filings of the 338 on record.

8-Ks, explained

Stress2Structure57Governance19
  • Oct 14, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Oct 2, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Structure4 sales of unregistered shares2026show all 4hide
    • Aug 19, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
    • Jul 13, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
    • Apr 2, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
    • Feb 23, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Dec 29, 25StressListing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Oct 24, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure3 material agreements entered2025show all 3hide
    • Oct 1, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jul 29, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jul 10, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 3, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Structure8 material agreements entered2022 – 2025show all 8hide
    • May 16, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jul 22, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jul 8, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jun 27, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Jun 6, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Nov 14, 23StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Oct 18, 22StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Sep 30, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

The record reaches back to Jan 30, 13.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Mitchell P. Kopin10.0%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • SEG Opportunity Fund, LLC7.1%Sep 29, 25SCHEDULE 13G ↗
  • AdvisorShares Trust6.7%Jun 30, 26SCHEDULE 13G ↗
  • Anson Funds Management LP4.9%Dec 31, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Renaissance Technologies LLC0.8%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Dec 15, 25Buy$1KEric WeisblumChief Executive Officer↗
  • Dec 15, 25Buy$1KEric WeisblumChief Executive Officer↗
  • Nov 21, 25Buy$365Eric WeisblumChief Executive Officer↗
  • Nov 20, 25Buy$370Eric WeisblumChief Executive Officer↗
  • Nov 19, 25Buy$2KEric WeisblumChief Executive Officer↗
  • Nov 18, 25Buy$3KEric WeisblumChief Executive Officer↗
  • May 27, 25Buy$4KEric WeisblumChief Executive Officer↗
  • Dec 13, 24Buy$2KEric WeisblumCEO and President↗
  • Nov 22, 24Buy$2KEric WeisblumCEO and President↗
  • Nov 20, 24Buy$2KEric WeisblumCEO and President↗
  • Jun 12, 24Buy$5KEric WeisblumCEO and President↗
  • Jun 11, 24Buy$607Eric WeisblumCEO and President↗

There are 22 more transactions in this stretch.

The full record holds 34 transactions and goes back to May 17, 23.

Its sector and its market

Silo Pharma Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Silo Pharma Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Silo Pharma Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
338 documents on file, from Mar 30, 2011 to Oct 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.